Active, Not Recruiting
Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT03190278
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
- Locations
-
- University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
- Northwestern University Chicago, Illinois, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States